Reported Sep 14, 2016 · Terminated
Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc. Irvine, CA…
Stason Pharmaceuticals, Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Stason Pharmaceuticals, Inc. · 11 Morgan · Irvine, CA · 92618-2005
Is this the product you have?
Selegiline HCL Tablets USP 5mg60- count bottlesRx only
- Manufactured byStason Pharmaceuticals, Inc. Irvine
- CA 92618 Distributed byLibertas Pharma, Inc. Montgomery, AL 36117. NDC 51862-146-06
- Lot codes and dates
Lot #: 14F03014F03114F032Exp. June 201715G022Exp. July 2018
- Amount recalled
- 17,013 units
Where it was sold
Why it was recalled
Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out of specification result for dissolution of stability samples.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Stason Pharmaceuticals, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.